Results 291 to 300 of about 70,538 (300)

Immunoglobulin replacement therapy in primary and secondary antibody deficiency: The correct clinical approach

International Immunopharmacology, 2017
Antonio Pecoraro, Francescopaolo Granata, Giuseppe Spadaro   +2 more
exaly  

NEW DATA ON COMBINED HORMONE REPLACEMENT THERAPY AND BREAST CANCER

Ca-A Cancer Journal for Clinicians, 2003
exaly  

The Current State of Hormonal Therapy for Prostate Cancer

Ca-A Cancer Journal for Clinicians, 2002
Kenneth J Pienta, Brent K Hollenbeck
exaly  

ESTROGEN/PROGESTIN HORMONE REPLACEMENT THERAPY RISKS OUTWEIGH BENEFITS: STUDY STOPPED EARLY DUE TO EXCESS BREAST CANCER, HEART DISEASE

Ca-A Cancer Journal for Clinicians, 2002
exaly  

LONG-TERM ESTROGEN REPLACEMENT THERAPY MAY INCREASE OVARIAN CANCER RISK

Ca-A Cancer Journal for Clinicians, 2001
exaly  

Uveitis after antineutrophil cytoplasmic antibody contamination of immunoglobulin replacement therapy

Lancet, The, 1992
exaly  

Navigating the ethical implications of immunoglobulin replacement therapy during pregnancy

Annals of Allergy, Asthma & Immunology
Timothy M. Buckey, Kathleen E. Sullivan
openaire   +2 more sources

High cost of immunoglobulin replacement therapy: Causes and implications.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2022
Di, Sun, Neil, Romberg
openaire   +1 more source

Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapy

Clinical and Experimental Immunology, 2012
exaly  

Can autoantibodies be transferred by immunoglobulin replacement therapy?

Scandinavian Journal of Immunology
openaire   +2 more sources